V. Primary Tumor Surveillance
Surveillance After the patient’s primary diagnosis, was surveillance done to detect distant disease (metastasis) ?*
Surveillance Plan How often was surveillance for metastasis done?
14%
Approximately every 3 months
91%
48%
Approximately every 6 months
13%
Approximately every 12 months
21%
Other
4%
9%
Unknown
Yes
No
How involved was the patient in deciding their surveillance plan?
The 91% of patients who responded “Yes” reported: Blood tests (i.e., liver function tests) 19%
18%
NOT AT ALL
Physical examination
10%
17%
A LITTLE BIT
30%
SOMEWHAT
Chest X-rays 11%
PET scan 7%
16%
QUITE A BIT
CT or CAT scan 18%
Ultrasound 7%
25%
VERY MUCH
MRI 19%
Other 2%
1%
UNKNOWN
* Please note: In this question, patients were able to check all that apply.
2022 VISION Registry Data Report
36
Made with FlippingBook Ebook Creator